M-CSF: a novel plasmacytoid and conventional dendritic cell poietin

被引:83
|
作者
Fancke, Ben [1 ]
Suter, Mark [1 ,2 ]
Hochrein, Hubertus [1 ]
O'Keeffe, Meredith [1 ]
机构
[1] Bavarian Nordic, Dept Res, D-82152 Martinsried, Germany
[2] Univ Zurich, Inst Virol, Zurich, Switzerland
关键词
D O I
10.1182/blood-2007-05-089292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The critical importance of plasmacytoid dendritic cells (pDCs) in viral infection, autoimmunity, and tolerance has focused major attention on these cells that are rare in blood and immune organs of humans and mice. The recent development of an Flt-3 ligand (FL) culture system of bone marrow cells has led to the simple generation of large numbers of pDCs that resemble their in vivo steady-state counterparts. The FL system has allowed unforeseen insight into the biology of pDCs, and it is assumed that FL is the crucial growth factor for these cells. Surprisingly we have found that a cell type with high capacity for interferon-alpha (IFN-alpha) production in response to CpG-containing oligonucleotides, a feature of pDCs, develop within macrophage-colony-stimulating factor (M-CSF)-generated bone marrow cultures. Analysis of this phenomenon revealed that M-CSIF is able to drive pDCs as well as conventional DCs (cDCs) from BM precursor cells in vitro. Furthermore, application of M-CSF to mice was able to drive pDCs and cDCs development in vivo. It is noteworthy that using mice deficient in FL indicated that the M-CSF-driven generation of pDCs and cDCs in vitro and in vivo was independent of endogenous FL.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 50 条
  • [41] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Economides, Minas P.
    Rizzieri, David
    Pemmaraju, Naveen
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 515 - 522
  • [42] Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report
    Grushchak, Solomiya
    Joy, Cossette
    Gray, Arielle
    Opel, Dan
    Speiser, Jodi
    Reserva, Jeave
    Tung, Rebecca
    Smith, Scott E.
    MEDICINE, 2017, 96 (51)
  • [43] Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
    Hernandez, Sabina Sanchez
    Jakobsen, Martin Roelsgaard
    Bak, Rasmus O.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [44] Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages
    Bonelli, Stefano
    Geeraerts, Xenia
    Bolli, Evangelia
    Keirsse, Jiri
    Kiss, Mate
    Antunes, Ana Rita Pombo
    Van Damme, Helena
    De Vlaminck, Karen
    Movahedi, Kiavash
    Laoui, Damya
    Raes, Geert
    Van Ginderachter, Jo A.
    FEBS JOURNAL, 2018, 285 (04) : 777 - 787
  • [45] M-CSF可溶性受体在烟草中的表达及其抗M-CSF作用研究
    郑国光
    杨应华
    饶青
    林永敏
    吴克复
    中国肿瘤生物治疗杂志, 2005, (04) : 275 - 279
  • [46] HIV-1 Nef interferes with M-CSF receptor signalling through hek activation and inhibits M-CSF bioactivities.
    Okada, S
    Suzu, S
    BLOOD, 2004, 104 (11) : 409A - 410A
  • [47] The influence of M-CSF on fracture healing in a mouse model
    Starlinger, Julia
    Sarahrudi, Kambiz
    Kecht, Mathias
    Koerbler, Florian
    Pietschmann, Peter
    Aharinejad, Seyedhossein
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [48] COEXPRESSION OF M-CSF TRANSCRIPTS AND PROTEIN, FMS (M-CSF RECEPTOR) TRANSCRIPTS AND PROTEIN, AND STEROID-RECEPTOR CONTENT IN ADENOCARCINOMAS OF THE OVARY
    KOMMOSS, F
    WOLFLE, J
    BAUKNECHT, T
    PFISTERER, J
    KIECHLESCHWARZ, M
    PFLEIDERER, A
    SAUERBREI, W
    KIEHL, R
    KACINSKI, BM
    JOURNAL OF PATHOLOGY, 1994, 174 (02): : 111 - 119
  • [49] REGULATION OF M-CSF EXPRESSION BY M-CSF - ROLE OF PROTEIN-KINASE-C AND TRANSCRIPTION FACTOR NF-KAPPA-B
    BRACH, MA
    HENSCHLER, R
    MERTELSMANN, RH
    HERRMANN, F
    PATHOBIOLOGY, 1991, 59 (04) : 284 - 288
  • [50] M-CSF、RANKL浓度及M-CSF预诱导对破骨细胞生成影响的研究
    董伟
    于静
    戚孟春
    白宇宏
    梁锐英
    陈槐卿
    生物医学工程学杂志, 2010, (06) : 1336 - 1340